| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1040900815 |
| P356 | DOI | 10.1111/J.1523-1755.2004.00803.X |
| P698 | PubMed publication ID | 15253733 |
| P5875 | ResearchGate publication ID | 8455270 |
| P2093 | author name string | Andrew P Evan | |
| James E Lingeman | |||
| Elaine M Worcester | |||
| Fredric L Coe | |||
| Joan H Parks | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 777-785 | |
| P577 | publication date | 2004-08-01 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. | |
| P478 | volume | 66 |
| Q94673538 | A Precision Medicine Approach Uncovers a Unique Signature of Neutrophils in Patients With Brushite Kidney Stones |
| Q84569904 | A chronic outcome of shock wave lithotripsy is parenchymal fibrosis |
| Q40689843 | Arguments for a comprehensive metabolic evaluation of the first-time stone former |
| Q30483669 | Assessment of renal injury with a clinical dual head lithotriptor delivering 240 shock waves per minute |
| Q91958416 | Association of Impaired Renal Function with Changes in Urinary Mineral Excretion and Stone Composition |
| Q38254465 | Association of serum biochemical metabolic panel with stone composition |
| Q35202298 | Brushite stone disease as a consequence of lithotripsy? |
| Q38358766 | Changes in stone composition over two decades: evaluation of over 10,000 stone analyses |
| Q86549144 | Changing stone composition profile of children with nephrolithiasis |
| Q40993374 | Characterization of Inner Medullary Collecting Duct Plug Formation Among Idiopathic Calcium Oxalate Stone Formers |
| Q46287834 | Citrate occurs widely in healthy and pathological apatitic biomineral: mineralized articular cartilage, and intimal atherosclerotic plaque and apatitic kidney stones. |
| Q35335724 | Clinical practice. Calcium kidney stones |
| Q34265048 | Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management |
| Q33835443 | Comparison of semi-empirical and computer derived methods for estimating urinary saturation of brushite |
| Q35000081 | Complete staghorn calculus in polycystic kidney disease: infection is still the cause |
| Q51536268 | Composition and morphology of phosphate stones and their relation with etiology. |
| Q46945491 | Continuous infusion of oxalate by minipumps induces calcium oxalate nephrocalcinosis |
| Q33582212 | Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones |
| Q34745710 | Correlation of the body mass index and calcium nephrolithiasis in adult population |
| Q93336469 | Current insights into the mechanisms and management of infection stones |
| Q35993936 | Current medical treatment in pediatric urolithiasis |
| Q30494162 | Detection of significant variation in acoustic output of an electromagnetic lithotriptor. |
| Q35050411 | Determinants of brushite stone formation: a case-control study |
| Q47142666 | Development of a novel magnetic resonance imaging acquisition and analysis workflow for the quantification of shock wave lithotripsy-induced renal hemorrhagic injury. |
| Q38116205 | Differences in 24-hour urine composition between apatite and brushite stone formers |
| Q37659357 | Differentiating calcium oxalate and hydroxyapatite stones in vivo using dual-energy CT and urine supersaturation and pH values |
| Q36314974 | Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria |
| Q84336121 | Effect of renal function on urinary mineral excretion and stone composition |
| Q36512771 | Effect of shock wave number on renal oxidative stress and inflammation |
| Q47919786 | Effectiveness of Treatment Modalities on Kidney Stone Recurrence |
| Q59789612 | Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial |
| Q92613197 | Evidence for a regulated Ca2+ entry in proximal tubular cells and its implication in calcium stone formation |
| Q36809019 | Evidence for altered renal tubule function in idiopathic calcium stone formers |
| Q33926506 | Extracorporeal shock wave lithotripsy at 60 shock waves/min reduces renal injury in a porcine model |
| Q41969015 | Factors predicting success of emergency extracorporeal shockwave lithotripsy (eESWL) in ureteric calculi--a single centre experience from the United Kingdom (UK). |
| Q33923986 | Fasting versus 24-h urine pH in the evaluation of nephrolithiasis |
| Q34532834 | Fetuin, matrix-Gla protein and osteopontin in calcification of renal allografts |
| Q42132088 | Fragility of brushite stones in shock wave lithotripsy: absence of correlation with computerized tomography visible structure |
| Q36446082 | Gas-containing renal stones: findings from five consecutive patients |
| Q57085952 | Glutamic acid inducing kidney stone biomimicry by a brushite/gelatin composite |
| Q39844900 | Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones |
| Q37633953 | Hypocitraturia: pathophysiology and medical management. |
| Q38906968 | Idiopathic hypercalciuria and formation of calcium renal stones |
| Q90415473 | Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers |
| Q36945018 | Increased propensity for calcium phosphate kidney stones with topiramate use. |
| Q36858765 | Intraluminal measurement of papillary duct urine pH, in vivo: a pilot study in the swine kidney |
| Q24536113 | Kidney stone disease |
| Q38186999 | Kidney stones during pregnancy |
| Q46602523 | Kidney stones during pregnancy: an investigation into stone composition |
| Q37169623 | Kidney stones: an update on current pharmacological management and future directions |
| Q37720686 | Lithotripsy |
| Q52586835 | Management of staghorn renal stones. |
| Q37221024 | Management of urolithiasis in pregnancy |
| Q35436905 | Mechanism by which shock wave lithotripsy can promote formation of human calcium phosphate stones |
| Q51248512 | Mechanism for Higher Urine pH in Normal Women Compared to Men. |
| Q28751145 | Medical treatment of pediatric urolithiasis |
| Q61443110 | Melamine promotes calcium crystal formation in three-dimensional microfluidic device |
| Q37366264 | Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement |
| Q38270121 | Metabolic evaluation of urinary lithiasis: what urologists should know and do. |
| Q84573076 | Metabolic syndrome and urinary stone composition: what factors matter most? |
| Q30053493 | Molecular modifiers reveal a mechanism of pathological crystal growth inhibition |
| Q49306097 | Nephrocalcinosis in Calcium Stone Formers Who Do Not have Systemic Disease |
| Q81295660 | Nephrolithiasis |
| Q35234971 | New methods of assessing crystal growth and saturation of brushite in whole urine: effect of pH, calcium and citrate |
| Q30450440 | Optimising an escalating shockwave amplitude treatment strategy to protect the kidney from injury during shockwave lithotripsy |
| Q36902337 | Pathogenesis of renal calculi |
| Q37913747 | Pathophysiology-based treatment of idiopathic calcium kidney stones |
| Q33731481 | Physiopathology and etiology of stone formation in the kidney and the urinary tract |
| Q64246327 | Predictors of Uric Acid Stones: Mean Stone Density, Stone Heterogeneity Index, and Variation Coefficient of Stone Density by Single-Energy Non-Contrast Computed Tomography and Urinary pH |
| Q30481624 | Pretreatment with low-energy shock waves induces renal vasoconstriction during standard shock wave lithotripsy (SWL): a treatment protocol known to reduce SWL-induced renal injury |
| Q35992704 | Pretreatment with low-energy shock waves reduces the renal oxidative stress and inflammation caused by high-energy shock wave lithotripsy |
| Q35214756 | Profile of the brushite stone former |
| Q34030752 | Protein content of human apatite and brushite kidney stones: significant correlation with morphologic measures. |
| Q36449199 | Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis |
| Q48119152 | Recurrence rates of urinary calculi according to stone composition and morphology. |
| Q53597545 | Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis. |
| Q83732379 | Relationships between carbonation rate of carbapatite and morphologic characteristics of calcium phosphate stones and etiology |
| Q39755764 | Renal crystal deposits and histopathology in patients with cystine stones. |
| Q62630729 | Renal histopathology of stone-forming patients with distal renal tubular acidosis |
| Q38955951 | Risk of Chronic Kidney Disease in Brushite Stone Formers Compared With Idiopathic Calcium Oxalate Stone Formers |
| Q44465282 | Shock wave lithotripsy: a randomized, double-blind trial to compare immediate versus delayed voltage escalation |
| Q30479949 | Shock wave lithotripsy: advances in technology and technique |
| Q34629795 | Stone composition as a function of age and sex. |
| Q75031121 | Stone-free Outcomes of Flexible Ureteroscopy for Renal Calculi Utilizing Computed Tomography Imaging |
| Q57627835 | TOF-SIMS VG Ionex IX23LS: upgrade and application for the urinary stones analysis |
| Q30480601 | The acute and long-term adverse effects of shock wave lithotripsy |
| Q38228579 | The change in upper tract urolithiasis composition, surgical treatments and outcomes of para and quadriplegic patients over time |
| Q98467226 | The correlation between demographic factors and upper urinary tract stone composition in the Thai population |
| Q39869394 | The influence of maternal and paternal history on stone composition and clinical course of calcium nephrolithiasis in subjects aged between 15 and 25. |
| Q28740580 | Three pathways for human kidney stone formation |
| Q30450212 | Treatment protocols to reduce renal injury during shock wave lithotripsy |
| Q37290751 | Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time |
| Q35848058 | Vascular Calcification and Stone Disease: A New Look towards the Mechanism. |
Search more.